-
Bridgestone Debuts Two New Truck Tyres for Mild On/Off Segment, Delivering Lasting Performance on Any Terrain - 3 hours ago
-
Combilift Unveils ‘The Grinch Christmas Video’ – A Festive Tale of Magic and Innovation - 3 hours ago
-
2024 Budget makes business case for warehouse tech more compelling - 1 day ago
-
WIALON AND QUECLINK WIRELESS SOLUTIONS TO SHARE GUIDANCE ON COLLABORATIVE TELEMATICS SOLUTIONS FOR FLEET SUCCESS - November 27, 2024
-
SURECAM AND BLACKOUT TECHNOLOGIES CREATE INDUSTRY-FIRST VIDEO TELEMATICS WITH INTEGRATED MOBILE DEVICE BLOCKING - November 26, 2024
-
ZEROMISSION TARGETS NORTH AMERICAN GROWTH WITH SENIOR BUSINESS DEVELOPMENT APPOINTMENT - November 25, 2024
-
DERRY BROS LAUNCHES AUTOMATED DECLARATIONS TO STREAMLINE CUSTOMS PROCESS FOR INTERNATIONAL FREIGHT MOVEMENTS - November 22, 2024
-
ROTOM GROUP EXPANDS UK PRESENCE WITH KINGSBURY PALLETS ACQUISITION - November 21, 2024
-
Scurri AI Concierge harnesses artificial intelligence to allow brands and retailers to enhance post-purchase experiences - November 14, 2024
-
AU VODKA PARTNERS WITH KAMMAC TO RAISE THE BAR ON LOGISTICS - November 13, 2024
Passive or Active? Supply chain leaders compare key pharmaceutical cold chain technologies in latest white paper
The vital role that temperature-controlled packaging plays in transporting pharmaceuticals around the world has been highlighted in a new white paper from Tower Cold Chain, with the aim of helping stakeholders find the right solution for their needs.
Compounded by the demands of the COVID-19 pandemic, the white paper provides practical advice on the various options available, with insight delivered by seven leading industry experts from across the supply chain. These include senior decision makers from Johnson & Johnson, DHL and LOT Polish Airlines, who deliver an unbiased guide that is ideal for specifiers in pharmaceuticals, 3PL and air freight looking to make informed choices.
Free to download from the Tower website, the white paper – titled ‘Passive v Active in a globally disrupted age’ – collates the key findings of a 90-minute webinar organised by Tower in late 2021. Amongst the topics covered are the rapid changes affecting the industry; the new challenges that are arising in delivering vaccines to remote areas; and the considerations that must be made in selecting the optimum container type for the task.
At the heart of the publication is an assessment of the relative merits of Active, Passive and Hybrid temperature-controlled packaging solutions with detailed insight on their use across the global pharmaceutical supply chain.
In an unbiased review of the technologies the white paper identifies a place for all types of temperature-controlled solutions within the market.
“In some circumstances, active methods are ideal. In others, passive is the only sensible choice to de-risk the shipment,” explains Kevin Doran, Global Head of Supply Chain at Tower Cold Chain.
“When it comes to patient care and the effective delivery of critical pharmaceuticals there’s no benefit in being partisan. We felt it was vital that decision makers can get a balanced view, which is why this white paper brings together a wide range of voices to survey the whole landscape and identify the scenarios for the best use of each technology.
“We’re grateful to all of the experts who gave their time and provide such a rich source of insight and information – and we look forward to sharing it with others.”
The white paper can be downloaded here.